Beta
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
Description
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
Founded
2016
Employees
180
Last Funding
1/31/2022
Funding Round
Venture - Series Unknown
Total Funding
$150,131,620
Specialty focus
Target Customer Segments
Digital Health Provider; Ambulatory Practice
For companies that serve
Technical details
Key customers
Alternatives
Will sign BAA
